Yang, Chenxuan
Liu, Jiaxiang
Zhao, Shuangtao
Shang, Qingyao
Ren, Fei
Feng, Kexin
Zhang, Ruixuan
Kang, Xiyu
Wang, Xin
Wang, Xiang
Funding for this research was provided by:
National Natural Science Foundation of China (82203688, 82072097)
Cancer Foundation of China (LC2022B24, LC2020A18)
Ministry of Science and Technology of the People’s Republic of China (2019YFE0110000)
Chinese Academy of Medical Sciences (2020-I2M-C&T-B-069)
Article History
Received: 5 December 2022
Accepted: 31 May 2023
First Online: 7 June 2023
Declarations
:
: The studies involving human participants were reviewed and approved by committees from the National Cancer Center and the Fourth Hospital of Hebei Medical University under the file number of 20/468–2664. Informed consent was acquired from patients involved in this study.
: The patients/participants provided their written informed consent to participate in this study. No potentially identifiable human images or data were presented in this study.
: The authors declare that they have no competing interests.